Mr. David Gordon reports
PHARMACIELO ANNOUNCES RSU GRANT
On Nov. 5, 2019, the board of directors approved and granted 25,000 restricted share units (RSUs) to Carlos Manuel Uribe, a director of Pharmacielo Ltd., which all vest on the grant date. Each RSU entitles the holder to receive one common share in the capital of the company upon vesting.
The RSUs are governed by the RSU plan approved by the shareholders of the company on May 23, 2019. The number of common shares that may be reserved for issuance pursuant to the awards granted under the RSU plan is 3,531,125. After this issuance of RSUs to Mr. Uribe, there are 1,158,000 RSUs issued and outstanding.
About Pharmacielo Ltd.
Pharmacielo is a global company, headquartered in Canada, with a focus on ethically and sustainably processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. Pharmacielo's principal (and wholly owned) subsidiary is Pharmacielo Colombia Holdings SAS, headquartered at its nursery and propagation centre located in Rionegro, Colombia.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.